1. Home
  2. NLSP vs TBI Comparison

NLSP vs TBI Comparison

Compare NLSP & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • TBI
  • Stock Information
  • Founded
  • NLSP 2015
  • TBI 1985
  • Country
  • NLSP Switzerland
  • TBI United States
  • Employees
  • NLSP N/A
  • TBI N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • TBI Professional Services
  • Sector
  • NLSP Health Care
  • TBI Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • TBI Nasdaq
  • Market Cap
  • NLSP 243.8M
  • TBI 223.4M
  • IPO Year
  • NLSP 2021
  • TBI 1996
  • Fundamental
  • Price
  • NLSP $4.45
  • TBI $7.20
  • Analyst Decision
  • NLSP
  • TBI Buy
  • Analyst Count
  • NLSP 0
  • TBI 2
  • Target Price
  • NLSP N/A
  • TBI $12.50
  • AVG Volume (30 Days)
  • NLSP 32.7K
  • TBI 223.7K
  • Earning Date
  • NLSP 10-18-2024
  • TBI 10-21-2024
  • Dividend Yield
  • NLSP N/A
  • TBI N/A
  • EPS Growth
  • NLSP N/A
  • TBI N/A
  • EPS
  • NLSP N/A
  • TBI N/A
  • Revenue
  • NLSP N/A
  • TBI $1,764,450,000.00
  • Revenue This Year
  • NLSP N/A
  • TBI N/A
  • Revenue Next Year
  • NLSP N/A
  • TBI N/A
  • P/E Ratio
  • NLSP N/A
  • TBI N/A
  • Revenue Growth
  • NLSP N/A
  • TBI N/A
  • 52 Week Low
  • NLSP $4.08
  • TBI $6.97
  • 52 Week High
  • NLSP $35.60
  • TBI $16.14
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 36.17
  • TBI 39.91
  • Support Level
  • NLSP $4.72
  • TBI $6.97
  • Resistance Level
  • NLSP $5.36
  • TBI $7.51
  • Average True Range (ATR)
  • NLSP 0.56
  • TBI 0.26
  • MACD
  • NLSP -0.01
  • TBI -0.02
  • Stochastic Oscillator
  • NLSP 19.79
  • TBI 21.50

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.

Share on Social Networks: